Source:http://linkedlifedata.com/resource/pubmed/id/18394318
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-4-8
|
pubmed:abstractText |
Hepatitis C Virus (HCV) infection can induce immunological disorders with different clinical expressions such as arthritis, Sjogren Syndrome and various forms of vasculitis. Retrospectively, the prevalence of anti-Cyclic Citrullinated peptide antibodies (anti-CCP) in a group of patients affected by HCV-related arthritis with positivity for Rheumatoid Factor (RF) and the eventual correlations with RF and/or Anti-Nuclear Antibodies (ANA) and articular involvement were studied. Thirty patients with arthritis were selected from a population of 380 subjects affected by HCV infection. Each patient was evaluated by clinical examination (23 denoted poliarticular and 7 mono-oligoarticular involvement), by X-graphic aspects of joint involvement (8 patients presented joint erosions), by ANA, RF and anti-CCP positivity. Ten of the HCV-related arthritis patients (33.3 percent) presented positivity for anti-CCP, without significant correlation between such parameter and ANA, RF and articular involvement. Anti-CCP resulted positive in 4 out of the 8 patients with joint erosions, and only in 6 out of the 22 patients without joint erosions. Such frequencies analyzed by chi square resulted with no significant differences. Our patients presented an interesting prevalence of the positivity for anti-CCP. These data are cause to consider the specificity recently attributed to this parameter in the diagnosis of rheumatoid arthritis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0393-974X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
57-61
|
pubmed:meshHeading |
pubmed-meshheading:18394318-Adult,
pubmed-meshheading:18394318-Antibodies, Antinuclear,
pubmed-meshheading:18394318-Arthritis,
pubmed-meshheading:18394318-Arthritis, Psoriatic,
pubmed-meshheading:18394318-Hepatitis C,
pubmed-meshheading:18394318-Humans,
pubmed-meshheading:18394318-Joints,
pubmed-meshheading:18394318-Peptides, Cyclic,
pubmed-meshheading:18394318-Retrospective Studies
|
pubmed:articleTitle |
Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis.
|
pubmed:affiliation |
Department of Clinical and Experimental Medicine, Federico II University Medical School of Naples, Italy.
|
pubmed:publicationType |
Journal Article
|